Van Strydonck, Gerald E.'s Form 4 filing
Vaccinex, Inc. (VCNX) · filed Feb 24, 2022
- Accession no.
- 0001062993-22-005567
- Filed
- Feb 24, 2022
- Trade date
- Feb 23, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $26.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Van Strydonck, Gerald E.CIK 0001748247 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2022 | Common Stock | PPurchaseAcquired | +2,000 | $1.30 | +$2,600 | 2,000 | Direct | |
| Feb 23, 2022 | Common Stock | PPurchaseAcquired | +18,000 | $1.32 | +$23,760 | 20,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.